Cheng et al. decorated two distinct antibodies on the surface of the EBPs, one targeting CD3 on T cells and the other targeting epidermal growth factor receptor (EGFR) on triple negative breast cancer (TNBC) cells [25]. This evidence concerns the gene EGFR and triple-negative breast carcinoma.